Plasma proteome and incident myocardial infarction: sex-specific differences.

Background and aims

Few population-based cohort studies, including both men and women, have explored circulating proteins associated with incident myocardial infarction (MI). This study investigated the relationships between circulating cardiometabolic-related proteins and MI risk using cohort-based and Mendelian randomization (MR) analyses and explored potential sex-specific differences.

Methods

The discovery cohort included 11 751 Swedish adults (55-93 years). Data on 259 proteins assessed with Olink proximity extension assays, biochemical, and questionnaire-based information were used. Participants were followed up for incident MI and death over 8 years through linkage to Swedish registers. Replication analyses were conducted on the UK Biobank sample (n = 51 613). In MR analyses, index cis-genetic variants strongly related to the proteins were used as instrumental variables. Genetic association summary statistic data for MI were obtained from the CARDIoGRAMplusC4D consortium and FinnGen.

Results

Forty-five proteins were associated with incident MI in discovery and replication samples following adjustment for potential confounders and multiple testing. In the secondary analysis, 13 of the protein associations were sex-specific, with most associations identified among women. In MR analysis, genetically predicted higher levels of renin, follistatin, and retinoic acid receptor responder protein 2 were linked to an increased risk of MI. Tissue factor pathway inhibitor, tumor necrosis factor receptors 1 and 2, placenta growth factor had an inverse association with MI.

Conclusions

This study identified both new and confirmed previously established associations between circulating proteins and incident MI and, for the first time, suggested sex-specific patterns in multiple protein-MI associations.

CommentIn

doi: 10.1093/eurheartj/ehae657

References:

• Palasubramaniam J, Wang X, Peter K. Myocardial infarction—from atherosclerosis to thrombosis. Arterioscler Thromb Vasc Biol 2019;39:e176–85. 10.1161/ATVBAHA.119.312578
• Dugani SB, Hydoub YM, Ayala AP, Reka R, Nayfeh T, Ding JF, et al. . Risk factors for premature myocardial infarction: a systematic review and meta-analysis of 77 studies. Mayo Clin Proc Innov Qual Outcomes 2021;5:783–94. 10.1016/j.mayocpiqo.2021.03.009
• Albrektsen G, Heuch I, Løchen M-L, Thelle DS, Wilsgaard T, Njølstad I, et al. . Lifelong gender gap in risk of incident myocardial infarction: the tromsø study. JAMA Intern Med 2016;176:1673–9. 10.1001/jamainternmed.2016.5451
• Schroder J, Jakobsen JC, Winkel P, Hilden J, Jensen GB, Sajadieh A, et al. . Prognosis and reclassification by YKL-40 in stable coronary artery disease. J Am Heart Assoc 2020;9:e014634. 10.1161/JAHA.119.014634
• Andersen T, Ueland T, Lakic TG, Åkerblom A, Bertilsson M, Aukrust P, et al. . C-X-C ligand 16 is an independent predictor of cardiovascular death and morbidity in acute coronary syndromes. Arterioscler Thromb Vasc Biol 2019;39:2402–10. 10.1161/ATVBAHA.119.312633